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Abstract: We present a low-cost, sensitive and specific DNA field-effect transistor sensor for the 
rapid detection of a common mutation to the tumour protein 53 gene (TP53). The sensor consists of 
a commercially available, low-cost, field-effect transistor attached in series to a gold electrode 
sensing pad for DNA hybridisation. The sensor has been predominantly optimised 
electrochemically, particularly with respect to open-circuit potentiometry as a route towards 
understanding potential (voltage) changes upon DNA hybridisation using a transistor. The 
developed sensor responds sensitively to TP53 mutant DNA as low as 100 nM concentration. The 
sensor responds linearly as a function of DNA target concentration and is able to differentiate 
between complementary and noncomplementary DNA target sequences. 
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1. Introduction 
Circulating tumour DNA (ctDNA) is an emerging biomarker for cancer which has the potential 
for early detection and monitoring of treatment response [1]. Rapid and accurate detection of 
important mutations, for example, tumour protein 53 (TP53), from the ctDNA fraction in a point-of-
care (PoC) manner represents a significant analytical challenge. To be able to detect a relatively small 
fraction of blood-borne DNA fragments originating from a tumour and carrying cancerous mutations 
against the background of the total circulating DNA requires the production of a device with both 
high sensitivity and specificity [2]. The current gold standard for tumour diagnosis is tissue biopsy; 
however, there is a clear need for a more effective method as it does not reliably detect early stage 
tumours or lesions [3]. The efficacy of tissue biopsy for monitoring changes to tumours throughout 
treatment is limited as the tissue sample reflects its molecular composition at the point of retrieval 
which means that by the time results are obtained, the tumour will have likely changed genetically. 
In addition, only one area of a tumour is characterised from a tissue biopsy, which is not ideal as 
different areas of a tumour can have different genetic profiles [4]. Therefore, a liquid-based approach 
to biopsy based on ctDNA could be revolutionary in early cancer diagnosis as living tumour cells are 
the final mechanism by which ctDNA can enter the blood [3]. Based on ctDNA analysis, real-time 
monitoring of tumours could be achieved. Therefore, it was decided to begin development of such a 
sensor using the genetic sequence from TP53 mutation, with which many types of cancer are 
associated. This mutation is useful to study because it correlates very closely with disease severity 
and is commonly employed in multiplex assays of ctDNA. 
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In recent years, there has been a growing demand for rapid PoC molecular diagnostic tests for a 
wide variety of diagnostic applications, including DNA detection [5–7]. The aim of such PoC tests is 
for them to be performed outside of the laboratory, either at the patient’s bedside or near-bedside, 
and could be of particular advantage in low/middle-income countries where resources/technical 
knowledge are limited, and early detection of various infectious diseases is critical to human health 
[8–10]. Useful PoC tests must be low-cost, portable, simple to use, sensitive and specific to the 
particular biomarker of interest. 
To date, many biosensors exist which feature different detection methods including optical 
techniques such as optical fibres to detect DNA or bacteria [11,12]. However, the drawbacks of 
optically based techniques are their cost-effectiveness, complexity and relative difficulty to 
implement into a PoC test. Electrochemical-based sensors, on the other hand, are a promising 
technology for use at the point of care and offer label-free detection, low-cost production, integration 
capabilities with technology such as microfluidics and can be integrated with low-cost electronics to 
provide real-time data capture and signal readout [13]. One such electrochemical technique is 
electrochemical impedance spectroscopy (EIS). With EIS, the impedance of the electrode–electrolyte 
interface is studied across a range of frequencies to establish information regarding the interface, 
electron-transfer and diffusional behaviour. Changes in impedance can be indicative of DNA 
detection. Differential pulse voltammetry (DPV) is another electrochemical technique of interest and 
can be used to sensitively investigate electron transfer to and from an electrode surface [14]. 
Previously, DNA sensors exploiting EIS and DPV have been produced for the detection of sepsis 
biomarker interleukin-6 (IL-6) [15], antibiotic resistance [16] and fusion genes [17].  
Open-circuit potentiometry (OCP) is an electrochemical technique which is used to measure the 
potential of an electrochemical system when there is no current flowing. It is a simple and highly 
sensitive technique and is useful for determining the potential within a system, particularly when a 
DNA sequence of interest is introduced. Previously, OCP has been exploited for the development of 
a platinum nanoparticle-based immunoassay for the detection of human chorionic gonadotropin 
hormone [18]. 
Field-effect transistors (FETs) can be used as a highly sensitive and low-cost approach for the 
detection of ctDNA as they can act as signal amplifiers [19]. FETs have the ability to achieve high 
sensitivity through amplification of the biorecognition signal resulting from complementary ctDNA 
from a clinical sample binding to probe DNA immobilised either at the FET gate or across the 
semiconductor channel. Such an approach could eliminate the need for polymerase chain reaction 
(PCR)-type amplification of tumour DNA mutations for detection [20], which is particularly 
attractive for use at the PoC as PCR both increases time to result and has high associated laboratory 
costs [20]. FETs typically consist of three terminals: the gate, source and drain. Controlling the voltage 
applied to the gate and drain terminals influences the current flow between the source and drain. As 
well as providing amplification, FETs offer the ability to directly transduce a change in voltage or 
current, useful for data capture and readout. This method is simpler than electrochemical techniques 
such as EIS, which requires circuit fitting to an equivalent circuit to interpret results, and is ultimately 
more amenable to a PoC setting. FETs, and particularly organic semiconductor variants which feature 
inherent advantages such as low-cost production and compatibility with flexible substrates [21,22], 
can also be mass produced via processes such as vacuum thermal evaporation [23,24] and printing [25], 
which results in high-volume/low-cost production. 
In this paper, we describe the steps taken to develop a FET-based sensor for the detection of 
common tumour protein mutation TP53 in ctDNA, particularly with the goal in mind of developing 
a route towards a liquid biopsy. We use an electrochemical-based approach initially, with a particular 
focus on the measurement technique OCP as the most representative technique by which a FET 
would read changes in solution, to optimise the electrode sensing pad for DNA hybridisation and 
detection, and then couple the sensing pad to the FET gate for signal transduction and DC voltage 
readout. The optimisation steps described herein are essential to be able to create a highly sensitive 
and specific sensor for a common TP53 mutation which is suitable for interfacing with a field-effect 
transistor sensor. 
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2. Materials and Methods 
2.1. Methodology 
Polycrystalline gold electrodes (PGEs) featuring a diameter of 2 mm were purchased from IJ 
Cambria (Llanelli, UK). Gold microelectrodes with diameters ranging from 1000 to 100 µm were 
fabricated in-house at the Strathclyde Institute of Photonics cleanroom facility. Commercially 
available n-channel enhancement mode field-effect transistors (2N7000) (FETs) were obtained from 
Farnell (Leeds, UK) and featured three terminals: gate, source and drain. Gold (Au) wire for the 
extended FET gate was purchased from Agar Scientific Ltd (Stansted, UK). All solutions were 
prepared using deionised (DI) water (Sigma Aldrich, Dorset, UK). Ferri-ferrocyanide (FF-C) 
(Fe[CN]63− + Fe[CN]64−) solution was prepared from the constituent components ferricyanide and 
ferrocyanide, which were obtained from Arcos Organics (Thermo Fisher Scientific, Geel, Belgium). 
All other chemicals including 3-Mercapto-1-propanol (MCP) and tris(2-carboxyethyl) phosphine 
(TCEP) were purchased from Sigma Aldrich. Table 1 provides information regarding the DNA 
sequences used for the study, including the DNA probe with and without spacer [SP18] and the 
complementary target tested. ctDNA mutation TP53 was chosen for investigation. All oligos were 
obtained from Sigma Aldrich and prepared in TRIS buffer. The complementary probe and target 
sequences were each 21 base pairs long. A 53-mer oligo was used as the noncomplementary control 
target. The same probe was used when testing noncomplementarity (specificity); only the target was 
substituted in this case. Figure S1 and Table S1 of the supporting information include additional data 
showing the specificity of the electrochemical part of the system to another ctDNA sequence (KRAS 
G12D) with only a single-base mismatch between the mutant and wildtype sequences. 
Table 1. DNA Probe and Target Sequences. 
Sequence Name Modification Sequence 5’–3’ 
Mutant type (MT) P53 
probe with spacer 
5’ thiol-CH 
SP18 
TTTGAGGTGCATGTTTGTGCC 
Mutant type (MT) P53 
probe without spacer 
5’ thiol-CH TTTGAGGTGCATGTTTGTGCC 
Mutant Type (MT) 
P53 target 
N/A GGCACAAACATGCACCTCAAA 
Noncomplementary 
DNA target 
N/A 
GGGAGAGAGAACTGGACGATGATGGGAATGGACTAAG
GATGACGGAAACAGAT 
Prior to functionalisation of the Au electrode ‘sensing pad’, all electrodes were cleaned following 
a well-established protocol involving immersion in Piranha solution, polishing with alumina slurry, 
sonicating for 5 min in DI water and then electrochemically cleaning by cyclic voltammetry (CV) in 
0.1 M sulphuric acid (H2SO4) to completely regenerate the PGE surface. The cleaning procedure 
produces a smooth and homogenous electrode surface for subsequent DNA functionalisation. 
Surface functionalisation was performed through the creation of a SAM (self-assembled monolayer) 
on the electrode surface, which was found to be reproducible between experiments. Electrodes were 
nominally incubated with 1 µM probe DNA and 5 µM tris(2-carboxyethyl) phosphine (TCEP) in DI 
water overnight. Electrodes were then rinsed in DI water to remove unbound DNA. Next, the 
electrodes were backfilled using 1 mM mercaptopropanol (MCP) (95% purity) and 5 mM TCEP in DI 
water for 1 h and then rinsed thoroughly in DI water. 
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2.2. Characterisation 
Electrochemical measurements on the PGE ‘sensing pad’ were performed using a three-
electrode cell. In addition to the PGE, the cell was completed by using a platinum wire counter 
electrode and a saturated Ag/AgCl reference electrode. All measurements were carried out using a 
potentiostat (PalmSens PS4, PalmSens, Houten, Netherlands). Once cleaned, electrodes were 
electrochemically characterised in a measurement solution of 2 mM FF-C. EIS, DPV and OCP 
measurements were performed consecutively in the same measurement solution to characterise the 
PGE. EIS measurements were performed between 100 kHz and 0.1 Hz at open-circuit potential using 
an amplitude of 10 mV r.m.s, and the complex impedance spectra were fitted to a Randles equivalent 
circuit to determine the charge transfer resistance (RCT). DPV was performed between –0.2 and 0.5 V 
and the peak current (Ipk) was extracted. OCP was performed for 10 s for regular static 
characterisation measurements, and up to 7200 s (2 hours) for continuous measurements. Scanning 
electron microscope (SEM) (TM-1000, Hitachi, Tokyo, Japan) images were taken of the Au (PGE) 
electrode surface to gain an impression of the surface profile. SEM images were performed by 
scanning a 30 × 30 µm area, at a magnification of ×5.0 k. The FET setup utilised a source-follower 
configuration (Figure 1c), with the Au electrode sensing pad connected to the FET gate via Au wire 
in the form of an extended gate. The drain and gate terminals were powered at 2 V DC (VGS = VDS = 2 V) 
and the source was grounded. The average voltage (potential) at the FET output across the source 
and drain was measured as a function of DNA concentration and compared to electrode sensing pad 
OCP measurements. FET potential measurements were recorded using a highly sensitive impedance 
analyser (Metrix MX 57EX). For every continuous OCP measurement and FET measurement 
performed, a minimum of three experiments were performed which were found to be entirely 
internally self-consistent. This negligible intra-experimental variation gave confidence that the 
reported effect of OCP as a function of target concentration and relative differences between 
complementary and noncomplementary sequences were reproducible. Representative data is 
displayed and error bars have not been included in this instance as a result of inter-experimental 
variation being higher, thus making error bars unrepresentative of the true effect. Inter-experimental 
variation was high because of electrode-to-electrode variation and variations in the electrode history, 
in addition to electrode cleaning processes. Furthermore, variations in the FET behaviour were 
observed, and going forward, being able to microfabricate FET devices could help to eradicate any 
batch-to-batch variations in FET response. In summary, these various factors related to both the 
electrode and FET structures will be the subject of future standardisation experiments. 
3. Results and Discussion 
3.1. Sensor Setup 
To effectively establish the optimum measurement setup for the FET sensor for TP53 detection, 
various experiments were performed to optimise the ‘sensing’ side of the device (i.e., the gold 
electrode). PGEs were chosen for this purpose and despite their relatively high cost compared to 
screen-printed electrodes (SPEs), they offer a higher quality Au surface which can be polished to a 
mirror finish, resulting in improved DNA detection, sensitivity and reproducibility between 
measurements [16]. Previously, PGEs have found use as enzymatic biosensors for peroxide detection 
and as chemical sensors amongst others [26,27]. For the investigation of electrode diameter, 
microfabricated gold electrodes were used. These were fabricated in-house in a cleanroom via a series 
of photolithography and etching steps. The 1000 µm diameter electrode was treated as the most 
comparable in terms of dimensions to the PGEs (2 mm) and would be classed as macroelectrodes. 
Smaller electrodes were treated as significantly different in diameter and for the purposes of this 
study were referred to as microelectrodes. A three-electrode cell was developed for electrochemical 
measurements featuring the PGE working electrode (WE), platinum counter electrode (CE) and 
Ag/AgCl reference electrode (RE). The PGE used for electrochemical measurements is presented in 
Figure 1a (i), with the Au electrode surface where the reaction takes place circled in red for clarity. 
To investigate the quality of the Au electrode surface, SEM was performed on the bare electrode. The 
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SEM image shown in Figure 1a (ii) shows that the PGE features a predominantly smooth surface 
profile, with only a few voids across the surface featuring nonhomogenous particle sizes. 
The sensor detection mechanism relies upon electrochemical changes at the Au WE surface 
when target DNA is attached to the surface, ultimately resulting in a change of the open-circuit 
potential which can be measured as a voltage change, suitable for readout via a FET. Figure 1b depicts 
a schematic of the DNA attachment protocol on the Au sensing pad surface, whereby initially single-
stranded (s-s) probe DNA is immobilised through semi-covalent bonding of the alkanethiol group to 
the gold, followed by the addition of target DNA of various concentrations. Probe–target 
hybridisation enables the formation of double-stranded (d-s) DNA. More information regarding the 
attachment process can be found in related work by Keighley et al. [28]. Electrochemical 
measurements were used to monitor changes between the probe-only surface (pre-target) and the 
surface with target DNA added (post-target) to ascertain the effect of target hybridisation on the 
electrode, and optimise various electrode parameters to obtain the greatest change between pre-target 
and post-target measurements. Upon optimisation of the electrode sensing pad, the FET element of 
the sensor was introduced. The FET sensor comprises a commercially available transistor which acts 
as the transducer. The FET gate is connected in series to the electrode sensing pad via Au wire, 
therefore the FET threshold voltage (Vt) should remain approximately constant. The system 
comprises a supply electrode, ultimately controlling the voltage applied to the gate (VGATE), the 
sensing pad electrode which behaves like a floating gate (VPAD) where DNA hybridisation occurs and 
the FET itself acting as transducer. It is possible to model the voltage dropped at the gate electrode 
through the addition of the sensing pad via an extended gate arrangement by relating the voltage to 
both the capacitance of the gate (CGATE) and the capacitance of the semiconductor channel (CFET) and 
their respective areas [29,30]. According to an investigation performed in [29] by S. P White et al., in 
order to reduce the effective voltage drop, the area of the gate must be at least 150 times greater than 
the area of the semiconductor. If this ratio is not satisfied, and the area of the gate is lowered 
compared to the semiconductor area, then transistor turn-on is not as sharp, FET ON current is 
reduced and there is also a noticeable hysteresis. In addition, using a simple lumped capacitor model 
as outlined in [29] where it is assumed that the semiconductor is held at ground and there is zero gate 
current, if CGATE >> CFET, then VPAD ≈ VGATE, a critical feature to ensure that the sharpest transistor turn-
on is achieved since negligible voltage is dropped. For the system presented here, the various 
capacitances and areas are unknown since a commercially available FET was used as a proof of 
concept; however, future device design would incorporate these crucial area and capacitance ratio 
elements to ensure as little voltage is dropped as possible, maintaining low-voltage device operation 
and ultimately increasing the sensitivity of the proposed system. However, in the case of the system 
presented, since the FET is connected in a source-follower configuration, we can make an 
approximation and model the device in the ideal situation, whereby the potential change induced by 
the addition of target DNA (ΔVDNA) should be the only system variable. Therefore, the expected 
system output should be approximately equal to the potential change through DNA addition as 
detailed in Equation (1): 
∆VOUT ≈ ∆VDNA (1) 
The advantage of using the extended gate approach has been demonstrated previously [22,31]; 
however, the main reason for doing so is to avoid additional complexity resulting from device 
encapsulation, as the transducing element (FET) is isolated from the sensing side. Figure 1c shows a 
schematic representation of the sensor setup, with the Au electrode sensing pad immersed in 
measurement solution, attached in series to the FET gate via Au wire. 
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Figure 1. (a) (i) Polycrystalline gold electrode (PGE) acting as ‘sensing pad’ element of (field-effect 
transistor) (FET) sensor device. (ii) Scanning electron microscope (SEM) image of Au PGE electrode 
surface at × 5 k magnification. (b) Schematic of the sensing pad surface showing probe DNA with and 
without the hybridised complementary DNA target. (c) FET sensor equivalent circuit showing Au 
electrode sensing pad connected via an extended gate to the FET input side. 
Figure 2a shows representative graphs of what should occur when target DNA is hybridised to 
the probe DNA on the electrode surface with regards to electrochemical measurements differential 
pulse voltammetry (DPV) (i), electrochemical impedance spectroscopy (EIS) (ii) and open-circuit 
potentiometry (OCP) (iii). DPV is a highly sensitive voltammetric method and features a series of 
voltage pulses superimposed on a potential linear sweep (e.g., staircase effect). The current is 
measured prior to each voltage change. EIS is used to monitor complex impedance changes within a 
system by applying a small AC voltage pulse and measuring the real and imaginary parts of the 
impedance as a function of frequency. OCP refers to the potential of an electrochemical system where 
no current is flowing and is the most accurate representation from an electrochemical perspective of 
what happens to the potential change within a FET system when detecting DNA. Upon attachment 
of target DNA, the electrode surface is deemed to be more ‘blocked’ (physically and electrostatically), 
therefore hindering the ability of an electrochemical redox mediator such as FF-C to penetrate to the 
electrode surface. This manifests itself as an increase in the charge transfer resistance (RCT) portion of 
EIS, and with an increased resistance, the DPV peak current and open-circuit potential should 
theoretically decrease according to Ohm’s law (see Figure 2a). 
Before connection to the FET side of the sensing circuit, the Au PGE sensing pad was optimised 
electrochemically via DPV, EIS and OCP measurements. Various parameters were investigated to 
optimise sensitivity of the Au pad for DNA detection including the electrode size, probe DNA 
concentration, probe DNA with and without a spacer between the DNA sequence and the thiol group 
and the composition of the measurement buffer in which measurements were performed. 
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Firstly, the effect of electrode size on the DNA measurement was investigated. Figure 2b (i) 
shows the effect of electrode diameter (100, 250 and 1000 µm) on the signal change between pre-target 
and post-target electrochemical measurements. These experiments were performed on 
microfabricated electrodes to obtain the smaller electrode diameters for comparison. As expected, 
DPV and OCP post-target resulted in a % decrease, whereas EIS resulted in an increase in RCT after 
target addition. It is clear that the greatest signal change regardless of measurement technique is 
produced by the largest (1000 µm) diameter electrode, and it also provides the most consistent change 
for OCP measurements. Therefore, coupled with the more reproducible surface and the trend of 
greater signal change with larger electrode diameter, the 2 mm PGE was chosen as the optimum 
electrode to take forward into further optimisation. 
Next, the concentration of probe DNA in immobilisation buffer was investigated to optimise the 
probe DNA density. Figure 2b (ii) shows DPV, EIS and OCP data for four different concentrations of 
probe DNA in the immobilisation solution (0.1, 0.5, 1 and 3 µM). Whilst the OCP appeared to show 
little difference, DPV and EIS showed the greatest decrease and increase, respectively, post-target 
addition for the 1 µM probe. To finalise the probe optimisation, a probe was designed which featured 
a spacer (SP18) at the 5’ end to ascertain whether extending the recognition sequence away from the 
surface and further into solution resulted in improved hybridisation of the target DNA, and 
ultimately, a greater change in OCP. For all measurements performed, the effect of the spacer was 
profound (Figure 2b (iii)) and actually resulted in a smaller change post-target than the original probe 
without spacer. This was an interesting find since in the literature, for electrochemical assays, there 
are many reports of spacers actually improving sensitivity [32,33] and therefore it was deemed 
worthwhile to investigate the effect of a spacer for this system. However, the fact that introduction 
of a spacer in this case resulted in a smaller change post-target could be an advantage for a FET-based 
system where the Debye length is a critical parameter to take into account. Therefore, going forward, 
a 2 mm diameter PGE electrode was used for all experiments, featuring a probe concentration of 1 
µM with no spacer. The final optimisation experiment performed was to investigate different 
measurement buffers to optimise the signal change with regards to OCP. Figure 2b (iv) shows the OCP 
signal change ratio using three different target DNA concentrations for comparison (10 nM, 100 nM 
and 1 µM). Five measurement buffers were tested (1 mM FF-C in 1× PBS, 2 mM FF-C in 1× PBS, 0.05× 
PBS only, 1× PBS only and 3× PBS only) (PBS = phosphate-buffered saline, pH ~ 7.2). Whilst FF-C is a 
common electrochemical redox mediator which will fix a well-defined OCP, the two ions involved 
have 4− and 3− charges giving rise to a high ionic strength, and therefore PBS was investigated to 
gauge the effect purely of salt concentration on the OCP of the system, particularly important for 
subsequent FET measurements where the Debye length is an important consideration to avoid 
potential electrostatic screening effects resulting in significantly reduced sensitivity of the FET system 
for DNA detection [34]. From Figure 2b (iv), it is clear that the 0.05× PBS measurement buffer 
provided the greatest signal change ratio (OCP reduction) of all the buffers. In all cases, there was 
clear differentiation between target concentration and OCP, which is promising for sensitive TP53 
detection at concentrations in the nM range. Based on these results, the best measurement buffer for 
subsequent measurements was chosen as the 0.05× PBS. 
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Figure 2. (a) Example electrochemical measurements (Differential pulse voltammetry (DPV) (i), 
Electrochemical impedance spectroscopy (EIS) (ii) and Open-circuit potentiometry (OCP) (iii)) 
depicting the effect of hybridisation with complementary target DNA compared to the initial ‘pre-
target’ measurements. Pre-target data is shown in red and post-target data in blue. (b) Au electrode 
sensing pad optimisation experiments: (i) electrode diameter, (ii) DNA probe concentration, (iii) DNA 
probe with/without spacer and (iv) effect of measurement buffer on different concentrations of target 
DNA. 
Primed with optimised probe data and the optimum measurement buffer for OCP 
measurements, the next step involved investigating how the open-circuit potential of the sensing 
system varied over an extended period of time. From Figure 2b (iv), it is clear that OCP varied as a 
function of target concentration, and the observed decrease was greater as target concentration 
increased. However, these OCP measurements are based on 10 s long measurements of OCP, and do 
not take into account longer-term changes in system stability. Figure 3a (i) shows the effect of 
performing a ‘continuous’ OCP measurement over a period of 7200 s (2 hours) to investigate the 
sensitivity of the Au PGE sensing pad to changes in target TP53 concentration. (Data from 0 to 1000 s is 
not shown due to the solution equilibrating and the data featured some noise which resulted in a 
poor representation of the subsequent potential changes). After a period of 30 min to allow the 
measurement buffer to stabilise (mixing or using a stirring bar could reduce the time required), the 
first concentration of target DNA (100 nM) was added to the mix. Every 30 min, an increased 
concentration of target DNA (250 nM followed by 500 nM) was added to establish system sensitivity 
around physiologically relevant levels [33]. It is clear that for the case of the complementary probe 
and target DNA sequences, as the concentration of target DNA was increased, there was a larger 
decrease in OCP. The red arrow in Figure 3a (i) highlights the effect of adding target DNA to the 
solution, whereby OCP decreased temporarily to a new steady-state position at that point in time. 
For comparison, a noncomplementary target sequence was examined using identical conditions to 
investigate the specificity of the developed sensor. It is encouraging to note that for the 
noncomplementary case, there was no tangible change in OCP when target DNA between 100 nM 
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and 500 nM was added to the system, indicating that no hybridisation was occurring between the 
probe and target. Figure 3a (ii) shows the new steady-state potential of the system when target DNA 
has been added as a function of target DNA concentration. In the case of the complementary target, 
the OCP potential decrease between the pre-target situation and after application of 500 nM target 
DNA was 23.01%, whereas for the noncomplementary sequence, the change over the same 
concentration range was only 2.78%. A useful biosensor should not only be sensitive, but specific also 
to the particular parameter of interest (ctDNA) which this system clearly offers. 
Since the OCP was proven to be sensitive to changes in target DNA, the final stage was to 
evaluate the low-cost FET as a means to monitor changes in potential, avoiding the need for more 
complex and costly OCP measurements. The sensor setup shown in Figure 1c was used, whereby the 
Au PGE sensing pad was connected in series to the FET gate via Au wire with a gate voltage and 
drain voltage of 2 V. An identical experiment to that shown in Figure 3a was performed using a 
complementary target sequence. Figure 3b shows the average FET potential upon addition of target 
DNA as a function of DNA concentration. It is clear that as the concentration of target DNA was 
increased from the pre-target condition up to a maximum of 500 nM, the FET potential increased 
from 487.7 mV to 488.6 mV, an increase of ~ 1 mV. Whilst this change is small, it is indeed measurable. 
Possible methods to increase the FET potential change have been hypothesised, including the use of 
thin-film transistors such as organic FETs or organic thin-film transistors (OTFTs) [22–24]. Such 
devices feature significantly smaller feature sizes with channel lengths in the micron range enabling 
greater charge carrier mobility and hence potential change. A second method to improve sensitivity 
of the sensor would be to take measurements using a semiconductor parameter analyser, enabling 
the sourcing and measurement of small voltages and currents (femto amps range), and the FET could 
act as an amplifier and current changes could be measured instead of potential. Optimising the 
applied gate and drain voltages to the FET could also improve sensitivity, and biasing the device in 
the subthreshold regime could be a good starting point for sensitivity improvement. However, the 
current setup does provide a modest change in potential for small changes in target DNA 
concentration, eliminating the need for more complex and costly electrochemical detection 
techniques. Interestingly, whilst the OCP decreases with increasing concentration of target DNA, the 
FET potential increases. This is most likely a result of how the FET is biased, and a change in biasing 
voltages or use of a p-channel FET could result in a potential decrease. However, regardless of the 
increase/decrease, the important aspect is that there is an apparent potential change for DNA target 
concentrations in the nM range and it is consistent. 
 
Figure 3. (a) (i) Continuous OCP measurement measuring change in potential as a function of 
increasing target DNA concentration over time. Graph shows the effect of complementary and 
noncomplementary target sequences on OCP. (a) (ii) Average OCP potential as a function of 
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increasing target DNA concentration for complementary and noncomplementary DNA target sequences. 
(b) Average FET potential as a function of increasing target DNA concentration for complementary 
DNA target. 
With regards to sensor performance, a similar study using a FET-based approach looking at PNA 
(peptide nucleic acid)–DNA detection was performed [31]. In this case, they found a potential shift of 
~70 mV when using 1 µM DNA. This is highly comparable with the change in OCP we have observed 
in Figure 3a, despite our lower DNA target concentration. In addition, a sensor using a GaN nanowire 
extended-gate FET was developed previously for TP53 detection [35]. The approach enabled very 
high sensitivity (attomolar range) and was specific between complementary and noncomplementary 
sequences. Another system using a FET biosensor for detection of mutant TP53 made use of an n-
type CMOS MOSFET as the transducer [34]. The system compared both wildtype and mutant TP53 
DNA, and after binding, a significant increase in FET drain current was noted with the wildtype 
sequence (~250 µA), whereas for the mutant sequence, the drain current only increased by ~20 µA for 
the same 100 nM target DNA concentration, confirming specificity of the system. In [36], the authors 
also provide validation for our increase in FET potential, since the TP53 protein which is positively 
charged shields the consensus DNA on the gate surface, and an increase in positive charge on the 
gate surface will increase the FET channel conductance, and thus the drain current, and in our case, 
potential, will increase. Whilst highly specific to TP53 DNA, the main drawback of these systems is 
their fabrication complexity as well as relatively high cost for development. 
This study provides a clear path towards using a FET-based biosensor for rapid (<30 min) and 
sensitive (nM) detection of TP53 as a promising route towards establishing point-of-care 
measurements relevant to cancer diagnosis. Next steps will involve optimising the FET sensitivity 
and initiating steps to microfabricate FETs to benefit from lower voltage operation, enhanced 
sensitivity and even device integration on flexible substrates more suitable for use at the point of care. 
4. Conclusions 
A low-cost, sensitive and specific electronics-based sensor system has been developed for the 
detection of TP53 mutations, as a route towards a simple, noninvasive assay for tumour formation. 
The proposed sensor features a field-effect transistor transducer for signal amplification and voltage 
readout. The sensor features a polycrystalline gold electrode as the sensing pad for DNA 
hybridisation, connected in series using an extended gate setup to the transistor gate for transduction. 
The sensor has been optimised with particular attention to the sensing side, and aspects including 
electrode diameter, probe DNA concentration, probe DNA sequence and measurement buffer have 
been explored electrochemically to ascertain the best parameters for detection. Electrochemical 
techniques including OCP have been explored as a model for subsequent potential changes through 
the FET system, for TP53 detection at different target concentrations. The sensor is able to sensitively 
respond via OCP to target concentrations as low as 100 nM within minutes, and is selective when a 
noncomplementary DNA target strand is introduced. When the sensing pad is connected to a low-
cost, commercially available field-effect transistor, the addition of target DNA up to a concentration 
of 500 nM resulted in a FET potential change of ~1 mV, which could be improved upon through the 
use of microfabricated FET devices or using changes in FET output current. The system paves the 
way towards a low-cost, sensitive and selective field-effect transistor biosensor for the accurate and 
rapid detection of circulating DNA biomarkers indicative of tumour formation without the 
requirement for more complex and costly electrochemical methods of detection. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: 
Voltammetric peak current percentage signal change for mutant and wildtype KRAS G12D target sequences; 
Table S1: KRAS G12D mutation oligo sequences. 
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